English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21.
A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
US presidential candidates Bernie Sanders and Cory Booker have tabled a bill that would force drug companies to adhere to government-set prices-or risk losing patent exclusivity.
The Swiss Federal Institute of Intellectual Property has failed to stop an Indian pharmaceutical and medicine wholesaler from registering the trademark ‘Swisslife Forever’ at the UK Intellectual Property Office.
The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases.
The Regents of the University of Michigan have sued an optical microscope manufacturer for allegedly infringed one of its patents.
The European Patent Office has made strides in streamlining its opposition procedures, new data from Mewburn Ellis has shown.
A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Seattle Genetics has asked the American Arbitration Association to help resolve a dispute with Daiichi Sankyo, alleging that the Japanese pharma company used its technology to create a number of drugs.